Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
Nektar Therapeutics
Type
Public
Industry Biopharmaceuticals
Founded 1990
Headquarters San Francisco, California
Revenue $148.92 million (As of 2013)
Website www.nektar.com

Nektar Therapeutics (Nektar)(NASDAQ: NKTR) is a stage-clinical biopharmaceutical company. The company was founded in 1990 and is based in San Francisco, California. The company develops new drug candidates by appliying its proprietary PEGylation and advanced polymer conjugate technologies to modify chemical structure of substances. It is a technology supplier to a number of pharmaceutical companies including Affymax, Amegen, Merck, Pfizer and UCB Pharma, etc. The company has developed the world's first inhalable non-injectable insulin, Exubera, which was awarded as the bronze award by Wall Street Journal for its technological breakthrough. Exubera was also recognized as the most innovative diabetes medicine of 2006 in Germany.

Investment goal date:
Dividends reinvested
Nektar Therapeutics NKTR report Q2 2017
Period
Date
Adjusted Actuals EPS
GAAP EPS
Q4 2017
2018-02-28
--
--
Q3 2017
2017-11-07
--
--
Q2 2017
2017-08-08
-0.3600
-0.3900
Q1 2017
2017-05-09
-0.4200
-0.4200
Q4 2016
2017-03-01
-0.2800
-0.2800
Q3 2016
2016-11-03
-0.3200
-0.3200
Q2 2016
2016-08-03
-0.3600
-0.3600
Q1 2016
2016-05-03
-0.1400
-0.1400
Q4 2015
2016-03-01
-0.4000
-0.4000
Q3 2015
2015-11-05
-0.0600
-0.0600
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
Bank of New York Mellon Corp
2125902
BlackRock Fund Advisors
13843692
BlackRock Inc.
20035546
BlackRock Institutional Trust Company, N.A.
3755197
BRIDGER MANAGEMENT, LLC
2937255
Camber Capital Management LLC
5400000
FIRST TRUST ADVISORS LP
2249950
FMR LLC
1947644
Invesco Ltd.
4260455
JPMORGAN CHASE & CO
2807422
OPPENHEIMER FUNDS INC
24010818
PRIMECAP MANAGEMENT CO/CA/
21453485
STATE STREET CORP
3961247
Vanguard Group, Inc
13607980
WESTFIELD CAPITAL MANAGEMENT CO LP
4030539
Major Shareholders
Name Relationship
Total Shares
Holding stocks
WHITFIELD ROY A
0.1100% (142000)
ILMN / INCY / NKTR /
ROBIN HOWARD W
0.1200% (152504)
NKTR /
GREER R SCOTT
0.1000% (130333)
WINGER DENNIS L
0.0300% (43250)
ARAY / NKTR / PCRX /
CHESS ROBERT
0.2200% (274223)
NKTR /
KUEBLER CHRISTOPHER A
0.0300% (40500)
NKTR / WAT /
WANG SUSAN
0.0200% (20000)
CRUS / NKTR / PINC / VECO /
Krivulka Joseph J
0.0600% (82000)
NKTR /
Gergel Ivan P.
0.0300% (41575)
ENDP / NKTR /
Lingnau Lutz
0.0200% (27450)
NKTR /
Labrucherie Gil M
0.0500% (63414)
NKTR /
Nicholson John
0.1800% (224066)
NKTR /
Thomsen Jillian B.
0.0400% (50838)
NKTR /
Hora Maninder
0.0500% (58233)
NKTR /
Doberstein Stephen K
0.0200% (31102)
NKTR /
Ghosh Rinko
0.0100% (9753)
NKTR /
% ()